8.40% p.a. Early Redemption Worst of GOAL

Underlying: AstraZeneca / Johnson & Johnson / Merck & Co. SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 53014155 / ISIN: CH0530141552

Last update 07.08.2020
  • Bid

    102.15 %
    Volume: 10'000

  • Ask

    103.15 %
    Volume: 10'000